{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-002098","form_type":"8-K","ticker":"CVRX","cik":"0001235912","company_name":"CVRx, Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.134438+00:00","generated_at":"2026-06-20T17:33:55.443636+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CVRx reports preliminary Q4 revenue up ~91-94% YoY; FY2023 guidance $35-38M","bullets":["Q4 2022 revenue $7.0-7.1M (+91-94% YoY); U.S. heart failure revenue $5.9M.","FY2022 revenue $22.3-22.4M (+71-72%); 106 active implanting centers (up from 91).","Cash and equivalents $106M as of Dec 31, 2022; 26 U.S. sales territories.","FY2023 guidance: revenue $35-38M, gross margin 78-79%, operating expenses $76-80M.","Q1 2023 revenue expected $7.1-7.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-002098","json":"https://secwatch.observer/filing/0001104659-23-002098.json","markdown":"https://secwatch.observer/filing/0001104659-23-002098.md","text":"https://secwatch.observer/filing/0001104659-23-002098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1235912/000110465923002098/0001104659-23-002098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1235912/000110465923002098/tm232626d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:33:55.443636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"414effe3522871eac0a99b4ebe992db8ecfd179a","claim":"CVRx, Inc. reported the full year of 2023 results: revenue between $35.0 million and $38.0 million. Guidance initiated.","evidence_excerpt":"Total revenue between $35.0 million and $38.0 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1235912/000110465923002098/0001104659-23-002098-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year of 2023"},{"label":"Revenue","value":"between $35.0 million and $38.0 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"7226a607a842e20d46316858881f479c3f0e1116","claim":"CVRx, Inc. reported the first quarter of 2023 results: revenue between $7.1 million and $7.5 million. Guidance initiated.","evidence_excerpt":"Total revenue between $7.1 million and $7.5 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1235912/000110465923002098/0001104659-23-002098-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter of 2023"},{"label":"Revenue","value":"between $7.1 million and $7.5 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"87c21c3d7e2377cab4b95e0d61f6b7e83aea3d55","claim":"CVRx, Inc. reported the quarter ended December 31, 2022 results: revenue in the range of approximately $7.0 million to $7.1 million.","evidence_excerpt":"Total revenue for the fourth quarter of 2022 is expected to be in the range of approximately $7.0 million to $7.1 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1235912/000110465923002098/0001104659-23-002098-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2022"},{"label":"Revenue","value":"in the range of approximately $7.0 million to $7.1 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"9635d5ce36d83abfe20c54c913b0fed60fa11a40","claim":"CVRx, Inc. reported the fiscal year ended December 31, 2022 results: revenue in the range of approximately $22.3 million to $22.4 million.","evidence_excerpt":"Total revenue for full year 2022 is expected to be in the range of approximately $22.3 million to $22.4 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1235912/000110465923002098/0001104659-23-002098-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2022"},{"label":"Revenue","value":"in the range of approximately $22.3 million to $22.4 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}